Part III: Selected reviews common childhood and adolescent infections and multiple sclerosis

Neurology

Volumn 49, Issue 2 SUPPL., 1997, Pages 42-54

  Granieri, Enrico ^a   Casetta, Ilaria ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT DISEASE; CASE CONTROL STUDY; CHILDHOOD DISEASE; CONFERENCE PAPER; DISEASE ASSOCIATION; HUMAN; INFECTION; MEDICAL LITERATURE; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; VIRUS PATHOGENESIS; ADOLESCENT; AGE DISTRIBUTION; CHILD; INCIDENCE; REVIEW; VIRUS INFECTION;

ADOLESCENT; AGE DISTRIBUTION; CASE-CONTROL STUDIES; CHILD; HUMANS; INCIDENCE; MULTIPLE SCLEROSIS; VIRUS DISEASES;

EID: 0031202297     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (73)

1. Marie P. Sclérose en plaques et maladies infectieuses. Prog Med 1884;12:287-289.
2. Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993;6:382-427.
3. Granieri E, Casetta I, Tola MR, et al. Multiple sclerosis: does epidemiology contribute to providing etiological clues? J Neurol Sci 1993;115(suppl):16-23.
4. Poser CM. The pathogenesis of MS: observations and reflections - a personal memoir. J Neurol Sci 1992;107:127-140.
5. Sadovnick AD, Ebers GC. Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 1993;20:17-29.
6. Riise T, Grønning M, Klauber MR, Barrett-Connor E, Nyland H, Albrektsen G. Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway. Am J Epidemiol 1991;133:932-939.
7. Detels R, Visscher B, Haile RW, Malmgren RM, Dudley JP, Coulson AH. Multiple sclerosis and age at migration. Am J Epidemiol 1978;108:386-393.
8. Poskanzer DC, Schapira K, Miller H. Multiple sclerosis and poliomyelitis. Lancet 1963;2:917-921.
9. Alter M, Zhen-xin Z, Davanipour Z, et al. Multiple sclerosis and childhood infections. Neurology 1986;36:1386-1389.
10. Alter M, Zhen-xin Z, Davanipour Z, Sobel E, Min Lai S, LaRue I. Does delay in acquiring childhood infection increase the risk of multiple sclerosis? Ital J Neurol Sci 1987;(suppl 6):11-16.
11. Johnson RT. The virology of demyelinating diseases. Ann Neurol 1994;36:S54-S60.
12. Whitaker JN, Kingsbury DW. Viruses and the pathogenesis of multiple sclerosis. Trends Neurosci 1984;7:57-60.
13. Ferrante P, Guerini FR. Le ipotesi dell' eziologia virale nella sclerosi multipla. In: Cazzullo CL, Ghezzi A, Zaffaroni M, Zibetti A, eds. Sclerosi multipla. Aspetti Eziopatogenetici e clinici. Milano: Masson, 1994:221-241.
14. Cook SD, Rohowsky-Kochan C, Bansil S, Dowling PC. Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand 1995;161(suppl.):34-42.
15. Adams JM, Imigawa DT. Measles antibodies in multiple sclerosis. Proc Soc Exp Biol 1962;111:562-566.
16. Pette E, Kuwert E. Evaluation of multiple sclerosis sera against measles antigen in the complement fixation test. Arch Ges Virusforsch 1965;16:141-147.
17. Henson TE, Brody JA, Sever JL, Dyken ML, Cannon J. Measles antibodies titres in multiple sclerosis patients, siblings and controls. JAMA 1970;211:1985-1988.
18. Adams JM, Brooks MB, Fischer ED, Tyler CS. Measles antibodies in patients with multiple sclerosis and other neurological and non-neurological diseases. Neurology 1970;20:1039-1042.
19. Norrby E. Viral antibodies in multiple sclerosis. Progr Mod Virol 1978;24:1-39.
20. Ammitzboll T, Clausen J. Measles antibody in serum of multiple sclerosis patients, their children, siblings and parents. Acta Neurol Scand 1972;48:47-56.
21. Panelius M, Salmi A, Halonen PE, Kivalo E, Rinne UK, Penttinen K. Virus antibodies in serum specimens from patients with multiple sclerosis, from siblings, and matched controls. A final report. Acta Neurol Scand 1973;49:85-107.
22. Vandvik B, Degré M. Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system. J Neurol Sci 1975;24:201-219.
23. Poskanzer DC, Sever JL, Sheridan JL, Prenney LB. Multiple sclerosis in the Orkney and Shetland Islands IV: viral antibody titers and viral infections. J Epidemiol Community Health 1980;34:258-264.
24. Arnadottir T. Measles and canine distemper virus antibodies in patients with multiple sclerosis determined by radioimmunoassay. Acta Neurol Scand 1980;62:81-89.
25. Cremer NE, Johnson KP, Fein G, Likowsky WH. Comprehensive viral immunology of multiple sclerosis. II. Analysis of serum and CSF antibodies by standard serologic methods. Arch Neurol 1980;37:610-615.
26. Visscher BR, Sullivan CB, Detels R, et al. Measles antibody titers in multiple sclerosis patients and HLA-matched and unmatched siblings. Neurology 1981;31:1142-1145.
27. Madden DL, Wallen WC, Houff SA, et al. Measles and canine distemper antibody. Presence in sera from patients with multiple sclerosis and matched control subjects. Arch Neurol 1981;38:13-15.
28. Bray PF, Bloomer LC, Salmon VC, Bagley MH, Larsen PD. Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 1983;40:406-408.
29. Compston DAS, Vakarelis BN, Paul E, McDonald WI, Batchelor JR, Mims CA. Viral infections in patients with multiple sclerosis and HLA-DR matched controls. Brain 1986;109:325-344.
30. Shirodaria PV, Haire M, Fleming E, Merrett JD, Hawkins SA, Roberts SD. Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol 1987;44:1237-1241.
31. Berr C, Fuel J, Clanet M, Ruidavets JB, Mas JL, Alperovitch A. Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrénées, France. Acta Neurol Scand 1989;80:46-50.
32. Hopkins RS, Indian RW, Pinnow E, Conomy J. Multiple sclerosis in Galion, Ohio: prevalence and results of a case-control study. Neuroepidemiology 1991;10:192-199.
33. Alperovitch A, Berr C, Cambon-Thomsen A, et al. Viral antibody titers, immunogenetic markers, and their interrelations in multiple sclerosis patients and controls. Hum Immunol 1991;31:94-99.
34. Nyland H, Mayr KM, Barrett-Connor E, Myrmel H, Riise T, Grønning M. Altered antibody pattern to Epstein-Barr virus but not to other herpes virus in multiple sclerosis. Proceedings from the closing symposium of Oslo International Think-tank on MS Epidemiology. Bergen, June 1995. L'Arcispedale S.Anna 1996;46(Suppl):17.
35. Alter M, Speer J. Clinical evaluation of possible etiologic factors in multiple sclerosis. Neurology 1968;18:109-116.
36. Cendrowski W, Wender M, Dominik W, Flejsierowicz Z, Owsianowski M, Popiel M. Epidemiological study of multiple sclerosis in western Poland. Eur Neurol 1969;2:90-108.
37. Wilhelm ES. Beziehungen zwischen Erkrankungen im Kindesalter und Multiple-Sklerose-Erkrankung. Schweiz Arch Neurol Psychiatr 1970;106:311-317.
38. Currier RD, Martin EA, Woosley PC. Prior events in multiple sclerosis. Neurology 1974;24:748-754.
39. Alter M, Cendrowski W. Multiple sclerosis and childhood infections. Neurology 1976;26:201-204.
40. Poskanzer DC, Prenney LB, Sheridan JL, YonKondy J. Multiple sclerosis in the Orkney and Shetland Islands. I. Epidemiology, clinical factors, and methodology. J Epidemiol Community Health 1980;34:229-239.
41. Poskanzer DC, Sheridan JL, Prenney LB, Walker AM. Multiple sclerosis in the Orkney and Shetland Islands. II. The search for an exogenous aetiology. J Epidemiol Community Health 1980;34:240-252.
42. Andersen E, Isager H, Hyllested K. Risk factors in multiple sclerosis: tuberculin reactivity, age at measles infection, tonsillectomy and appendectomy. Acta Neurol Scand 1981;63: 131-135.
43. Sullivan CB, Visscher B, Detels R. Multiple sclerosis and age at exposure to childhood diseases and animals: cases and their friends. Neurology 1984;34:1144-1148.
44. Operskalski EA, Visscher BR, Malmgren RM, Detels R. A case-control study of multiple sclerosis. Neurology 1989;39: 825-829.
45. Helmick CG, Wrigley JM, Zack MM, et al. Multiple sclerosis in Key West, Florida. Am J Epidemiol 1989;130:935-949.
46. Italian Multiple Sclerosis Study Group. Migration and infectious diseases in etiology of multiple sclerosis: a case-control study. In: Battaglia MA, ed. Multiple sclerosis research. Amsterdam, Elsevier Science Publishers, 1989:147-156.
47. Koch-Henriksen N. An epidemiological study of multiple sclerosis, familial aggregation, social determinants, and exogenic factors. Acta Neurol Scand 1989;80(suppl 124):1-123.
48. Souberbielle BE, Martin-Mondiere C, O'Brien ME, Carydakis C, Cesaro P, Degos JD. A case-control epidemiological study of MS in the Paris area with particular reference to past disease history and profession. Acta Neurol Scand 1990;82:303-310.
49. Hays P. Multiple sclerosis and delayed mumps. Acta Neurol Scand 1992;85:200-203.
50. Grønning M, Riise T, Kvale G, Albrektsen G, Midgard R, Nyland H. Infections in childhood and adolescence in multiple sclerosis. A case-control study. Neuroepidemiology 1993;12: 61-69.
51. Lauer K, Firnhaber W. Descriptive and analytical epidemiological data on multiple sclerosis from a long-term study in southern Hesse, Germany. In: Lauer K, Firnhaber W, eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach-Bergstrasse: Leuchtturm-Verlag/LTV Press, 1994: 147-158.
52. Casetta I, Granieri E, Malagù S, et al. Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy. Neuroepidemiology 1994;13:120-127.
53. Milonas I. Epidemiological data of multiple sclerosis in northern Greece. In: Lauer K, Firnhaber W, eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach-Bergstrasse: Leuchtturm-Verlag/LTV Press, 1994:332-333.
54. Materljan E. [Magnitude and distribution of multiple sclerosis in Gorski Kotar, Crotia.] Thesis, 1994.
55. Gusev E, Boiko AN, Lauer K, Riise T, Deomina T. Environmental risk factors in MS: a case-control study in Moscow. Acta Neurol Scand 1996;94:386-394.
56. Allison RS, Millar JHD. Prevalence and familial incidence of disseminated sclerosis. A report to the Northern Ireland Hospital authority on the results of a three-year survey. Ulster Med 1954; 23(suppl 2):1-92.
57. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
58. McDonald WI, Halliday AM. Diagnosis and classification of multiple sclerosis. Br Med Bull 1977;33:4-9.
59. Schumacher GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis-report by the Panel on the Evaluation of Experimental Trials of Therapy in Multiple Sclerosis. Ann NY Acad Sci 1965;122:552-568.
60. Bauer HJ. Judgement of the validity of a clinical MS diagnosis. Acta Neurol Scand 1972;50(suppl 58):71-74.
61. McAlpine D, Lumsden CE, Acheson ED. Multiple sclerosis - a reappraisal. 2nd ed. Edinburgh: Churchill-Livingstone, 1972: 101-103.
62. Rosati G. Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview. Ann Neurol 1994; 36(suppl 2):S164-S174.
63. Poser CM. The epidemiology of multiple sclerosis: a general overview. Ann Neurol 1994;36(suppl 2):S180-S193.
64. Granieri E, Casetta I, Tola MR. Epidemiology of multiple sclerosis in Italy and southern Europe. Acta Neurol Scand 1995;91(suppl 161):60-70.
65. Martyn CN, Cruddas M, Compston DAS. Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry 1993;56:167-168.
66. Visscher B, Liu K, Sullivan C, et al. Birth order and multiple sclerosis. Acta Neurol Scand 1982;66:209-215.
67. Matias-Guiu J, Ferri L, Falip R, Galiano L, Martin R. Birth order in multiple sclerosis: a population-based case-control study in Alcoi, Spain. Neuroepidemiology 1994;13:129-130.
68. Gaudet JPC, Hashimoto L, Sadovnick AD, Ebers GC. A study of birth order and multiple sclerosis in multiplex families. Neuroepidemiology 1995;14:188-192.
69. Isager H, Anderson E, Hyllested K. Risk of multiple sclerosis inversely associated with birth order position. Acta Neurol Scand 1980;61:393-396.
70. Zilber N, Kutai-Berman M, Kahena E, Korczyn AD. Multiple sclerosis and birth order. Acta Neurol Scand 1988;78:313-317.
71. Linberg C, Andersen O, Vahlne A, Dalton M, Runmarker B. Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology 1991;10:62-65.
72. Haahr S, Koch-Henriksen N, Møller-Larsen A, Eriksen LS, Andersen HMK. Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study. Multiple Sclerosis 1995;1:73-77.
73. Ragozzino MV, Kurland LT. Epidemiologic investigation of the association between herpes zoster and multiple sclerosis. Neurology 1983;33:648-649.